Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Eliem Therapeutics, Inc. (ELYM)

2.85   -0.04 (-1.38%) 08-18 07:02
Open: 2.81 Pre. Close: 2.89
High: 3 Low: 2.7601
Volume: 18,340 Market Cap: 76(M)
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase IIa clinical trial; and ETX-155 for the treatment of major depressive disorder, perimenopausal depression, and focal onset seizures that is in Phase I clinical trial. The company also develops preclinical pipeline programs, such as Kv7 Program for pain, epilepsy, and depression; and Anxiolytic for the treatment of generalized anxiety disorder. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3 - 3.02 3.02 - 3.03
Low: 2.72 - 2.74 2.74 - 2.75
Close: 2.82 - 2.85 2.85 - 2.87

Technical analysis

as of: 2022-08-17 4:22:58 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.18     One year: 4.89
Support: Support1: 2.59    Support2: 2.16
Resistance: Resistance1: 3.58    Resistance2: 4.19
Pivot: 2.94
Moving Average: MA(5): 2.9     MA(20): 3
MA(100): 4.28     MA(250): 10.04
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 31.6     %D(3): 32.2
RSI: RSI(14): 39.2
52-week: High: 29.69  Low: 2.51
Average Vol(K): 3-Month: 67 (K)  10-Days: 33 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ELYM ] has closed above bottom band by 27.1%. Bollinger Bands are 81.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 30 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 17 Aug 2022
Eliem Therapeutics (NASDAQ:ELYM) Price Target Lowered to $4.00 at SVB Leerink - Defense World

Tue, 02 Aug 2022
Wall Street Falters Pre-Bell as Pelosi's Expected Taiwan Visit Fuels Geopolitical Uncertainty - InvestorsObserver

Tue, 02 Aug 2022
Sector Update: Health Care Stocks Weaken in Choppy Session - InvestorsObserver

Tue, 02 Aug 2022
Eliem Therapeutics Shares Fall After Lead Program Scuttled >ELYM - MarketWatch

Mon, 18 Jul 2022
Eliem Announces Updated Development Plans and the Advancement of ETX-155 for the Treatment of Major Depressive Disorder -

Mon, 16 May 2022
Eliem Therapeutics Reports First Quarter Financial and Business Highlights - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 27 (M)
Shares Float 2 (M)
% Held by Insiders 33.1 (%)
% Held by Institutions 74.7 (%)
Shares Short 382 (K)
Shares Short P.Month 756 (K)

Stock Financials

EPS -2.54
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 5.84
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -24.3
Return on Equity (ttm) -41.1
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow -40 (M)
Levered Free Cash Flow -24 (M)

Stock Valuations

PE Ratio -1.13
PEG Ratio 0
Price to Book value 0.48
Price to Sales 0
Price to Cash Flow -1.89

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.